DS
EPIX

DRW Securities’s ESSA Pharma EPIX Stock Holding History

DRW Securities’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,054
Closed -$155K – 308
2019
Q4 		$155K Hold
23,054
– – 0.01% 214
2019
Q3 		$103K Buy
+23,054
New +$56.9K 0.01% 132
2018
Q3 		– Sell
-33,857
Closed -$128K – 64
2018
Q2 		$128K Buy
+33,857
New +$127K 0.01% 84

Other funds holding EPIX

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

DRW Securities's EPIX Position: Q1 2020 in Review

DRW Securities sold out of ESSA Pharma (EPIX) in Q1 2020, closing a stake of 23,054 shares — an estimated $155K sold.

DRW Securities first reported a position in EPIX in Q2 2018 and held it in 3 quarters. The position peaked at $155K in Q4 2019. 17 funds tracked by Wall St. Rank hold EPIX as of Q1 2020.

  • DRW Securities reported no remaining ESSA Pharma position as of Q1 2020 after selling out during the quarter.
  • DRW Securities sold 23,054 ESSA Pharma shares in Q1 2020, an estimated $155K.
  • DRW Securities first reported a position in ESSA Pharma in Q2 2018 and held it in 3 quarters.
  • DRW Securities's ESSA Pharma position peaked at $155K in Q4 2019.
  • 17 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2020.

Based on DRW Securities's 13F filing for Q1 2020, filed 13 May 2020.